Sara Ibrahim

Dr. Sara Ibrahim


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2016 in Journal of Molecular Liquids
Verified
Journal Article
Closed access
SISara Ibrahim
Sara Ibrahim
HSHuda M. Sayed
Huda M. Sayed
AEAmira Mohamed EL-Rafei
Amira Mohamed EL-Rafei
AAAzza El Amir
Azza El Amir
MIMohammed Ismail
Mohammed Ismail
Nageh K AllamNageh K Allam
Nageh K Allam

4 October 2018 in Biomedicines
Verified
Journal Article
Open access
PDF file
MIMohamed Ismail
Mohamed Ismail
SISara Ibrahim
Sara Ibrahim
AEAzza El-Amir
Azza El-Amir
AEAmira Mohamed EL-Rafei
Amira Mohamed EL-Rafei
Nageh K AllamNageh K Allam
Nageh K Allam
AAAhmed Abdellatif
Ahmed Abdellatif
Innovative drug-delivery systems offer a unique approach to effectively provide therapeutic drug dose over the needed time to achieve better tissue protection and enhanced recovery. The hypothesis of the current study was to test the antioxidant and anti-inflammatory effects of genistein and nanofibers on the spinal cord tissue following experimental spinal cord injury (SCI). Rats were treated post SCI with genistein that is loaded on chitosan/polyvinyl alcohol (CS/PVA) nanofibers as an implantable drug-delivery system. SCI caused marked oxidative damage and inflammation, as is evident by the reduction in the super oxide dismutase (SOD) activity and the level of interleukin-10 (IL-10) in injured spinal cord tissue, as well as the significant increase in the levels of nitric oxide (NO), malondialdehyde (MDA), and tumor necrosis factor-alpha (TNF-α). Treatment of rats post SCI with genistein and CS/PVA nanofibers improved most of the above-mentioned biochemical parameters and shifted them toward the control group values. Genistein induced an increase in the activity of SOD and the level of IL-10, while causing a decrease in NO, MDA, and TNF-α in injured spinal cord tissue. Genistein and CS/PVA nanofibers provide a novel combination for treating inflammatory nervous tissue conditions, especially when combined as an implantable drug-delivery system.

8 June 2020 in Nanoscale Advances
Verified
Journal Article
Open access
PDF file
SISara Ibrahim
Sara Ibrahim
MRMarwan Rezk
Marwan Rezk
MIMohammed Ismail
Mohammed Ismail
TATaghrid Abdelrahman
Taghrid Abdelrahman
MSMona Sharkawy
Mona Sharkawy
Nageh K AllamNageh K Allam
Nageh K Allam
Pyrroloquinoline quinone (PQQ), present in breast milk and various foods, is highly recommended as an antioxidant, anti-inflammatory agent, and a cofactor in redox reactions in several biomedical fields.

23 September 2024 in Microbiology Research
Verified
Journal Article
Open access
PDF file
AAAmer Al Ali
Amer Al Ali
MAMohammed Haidar Abu-Alghayth
Mohammed Haidar Abu-Alghayth
KGKhaled Ismail Ghaleb
Khaled Ismail Ghaleb
SISara Ibrahim
Sara Ibrahim
Sepsis is characterized by multiple organ dysfunction, which is now accepted to be due to oxidative damage. The lung is the first organ exposed to this damage, and its injury is one of the leading causes of death. Therefore, many pharmacological strategies are employed to attenuate sepsis. This study aimed to evaluate the in silico and in vitro antibacterial activity of Cicer arietinum extract (CAE) against Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa and the in vivo modulatory effect of CAE against sepsis induced by cecal ligation and puncture (CLP) in rats. This study identified seven bioactive components in Cicer arietinum extract, revealing promising interactions between these components and Staphylococcus aureus-PBP2a and Pseudomonas aeruginosa-PBP3 proteins, highlighting their potential as novel antibacterial agents. After ensuring the bactericidal ability of CAE against Staphylococcus aureus and Pseudomonas aeruginosa, an in vivo study was performed. Twenty-four rats were divided into sham-operated rats, CLP-septic rats, CLP rats treated with CAE (500 mg/kg b.wt), and CLP rats treated with hydrocortisone (25 mg/ kg b.wt). CAE was administered orally for 3 days post-operation, and animals were euthanized on the fourth day. Another twenty-four rats were used to study survival for 5 days. This study revealed that CAE, like hydrocortisone, can rescue CLP rats from death by suppressing lung procalcitonin (PCT) and MDA and enhancing SOD, CAT, and GSH levels significantly, as compared with the CLP group. The histopathological results were parallel with the biochemical results since the CLP rats treated with CAE had lower histological/inflammatory scores in the lung like hydrocortisone. The beneficial role of CAE may result from its antibacterial and antioxidant activities, and CAE can be considered as a lung antiseptic extract. This study provides a novel treatment for sepsis-induced ALI. However, the beneficial impact of CAE needs extensive study to obtain evidence.